Send  your Name and Email Address and receive more info on Foundation and Research

Article Index



Mervyn Rothstein interviews 

Orion P. Keifer, Jr., M.D., Ph.D.



Orion P. Keifer, Jr., M.D., Ph.D., is Vice President for discovery and translation at CODA Biotherapeutics Inc. in South San Francisco, California.   He is a neuroscientist with neurosurgical expertise in small and large animal models, focused on small molecule, biologics, and cell and gene therapies for neurological diseases. 

 Before joining CODA, a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform to treat neurological diseases, he worked as a consultant translational scientist and surgeon for Above and Beyond, focusing on precision medicine for neurodegenerative disorders.  Keifer earned a M.D. and a Ph.D. in neuroscience from Emory University, and a M.S. in brain and cognitive neurosciences and B.S. degrees in biomedical engineering, applied psychology and applied biology with Highest Honors from Georgia Tech. He completed his post-doctoral training in the Department of Neurosurgery at Emory University.  

He spoke with Mervyn Rothstein, who was a reporter and editor at The New York Times for 30 years, and whose first symptoms of Trigeminal Neuralgia appeared in 2005.  

MR: Tell us about your Trigeminal Neuralgia-related research study project, and its place and importance in the search for a cure.


Copyright © 2021 The Facial Pain Research Foundation. All Rights Reserved.
Joomla! is Free Software released under the GNU General Public License.